EFI
ABBV icon

EHP Funds Inc’s AbbVie ABBV Stock Holding History

EHP Funds Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,100
Closed -$360K – 44
2024
Q2 		$360K Buy
+2,100
New +$348K 0.18% 65
2023
Q4 		– Sell
-1,700
Closed -$253K – 198
2023
Q3 		$253K Sell
1,700
-7,700
-82% -$1.13M 0.12% 129
2023
Q2 		$1.27M Sell
9,400
-10,900
-54% -$1.6M 0.31% 82
2023
Q1 		$3.24M Sell
20,300
-2,600
-11% -$397K 0.63% 55
2022
Q4 		$3.7M Sell
22,900
-1,500
-6% -$230K 0.7% 61
2022
Q3 		$3.27M Buy
24,400
+12,600
+107% +$1.81M 0.66% 70
2022
Q2 		$1.81M Buy
11,800
+5,700
+93% +$871K 0.3% 104
2022
Q1 		$989K Buy
+6,100
New +$886K 0.16% 131

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

EHP Funds Inc's ABBV Position: Q3 2024 in Review

EHP Funds Inc sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 2,100 shares — an estimated $360K sold.

EHP Funds Inc first reported a position in ABBV in Q1 2022 and held it in 8 quarters. The position peaked at $3.7M in Q4 2022. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • EHP Funds Inc reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
  • EHP Funds Inc sold 2,100 AbbVie shares in Q3 2024, an estimated $360K.
  • EHP Funds Inc first reported a position in AbbVie in Q1 2022 and held it in 8 quarters.
  • EHP Funds Inc's AbbVie position peaked at $3.7M in Q4 2022.
  • 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on EHP Funds Inc's 13F filing for Q3 2024, filed 14 Nov 2024.